Co-Diagnostics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 64.4% | 64.4% | -148.8% |
| FY2017 | -180.7% | -180.7% | -149.3% |
| FY2018 | 592.3% | -738.1% | -403.8% |
| FY2019 | -356.6% | -356.6% | -279.7% |
| FY2020 | 63.7% | 63.7% | 59.6% |
| FY2021 | 27.3% | 27.3% | 22.9% |
| FY2022 | -12.4% | -12.4% | -11.6% |
| FY2023 | -41.3% | -41.3% | -37.1% |
| FY2024 | -69.9% | -69.9% | -59.2% |
| FY2025 | -227.3% | -227.3% | -189.5% |